Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FamiCord AGVTIAF 54 3-Year EPS without NRI Growth Rate is 47.10% as of Mar. 2026, which is 1306% above its 10-year median of 3.35. GuruFocus rates VTIAF with a GF Score™ of 54/100 and a GF Value™ of $10.18. The stock has 3 warning signs investors should review. Among 506 Healthcare Providers & Services companies, FamiCord AG ranks better than 86.36% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 47.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of FamiCord AG was 47.10% per year. The lowest was -31.30% per year. And the median was 3.35% per year.
FamiCord AG (OTCPK:VTIAF) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
FamiCord AG 3-Year EPS without NRI Growth Rate Related Terms
VTIAF vs HCA, THC, DVA: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, FamiCord AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FamiCord AG 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, FamiCord AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where FamiCord AG's 3-Year EPS without NRI Growth Rate falls into.
FamiCord AG 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 47.10% mean?
FamiCord AG (VTIAF) has a 3-Year EPS without NRI Growth Rate of 47.10% as of Mar. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for FamiCord AG and its competitors. This is 1306% above median its historical median of 3.35. According to the industry distribution chart, FamiCord AG ranks #69 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 13.6%.
Is FamiCord AG's 3-Year EPS without NRI Growth Rate too high?
FamiCord AG's current 3-Year EPS without NRI Growth Rate of 47.10% is 1306% above median its 10-year median of 3.35. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.00. FamiCord AG's value of 47.10% is 328.2% above this industry median. Based on the distribution chart, FamiCord AG ranks #69 out of 506 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, FamiCord AG has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does FamiCord AG's 3-Year EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, FamiCord AG ranks #69 out of 506 companies for 3-Year EPS without NRI Growth Rate. This places FamiCord AG in the top 14% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 11.00. FamiCord AG's value of 47.10% is 328.2% above this benchmark. While the company's 10-year median is 3.35 vs. the industry median of 11.00, FamiCord AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.00, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. FamiCord AG's current 3-Year EPS without NRI Growth Rate of 47.10% is 328.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for FamiCord AG and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FamiCord AG's current 3-Year EPS without NRI Growth Rate is 47.10%, which is 1306% above median its own 10-year median of 3.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FamiCord AG stock overvalued right now?
FamiCord AG (VTIAF) has a current 3-Year EPS without NRI Growth Rate of 47.10%. The stock's GF Value™ is $10.18, compared to a current price of $6.38 — trading 37.4% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 47.10%, which is 1306% above median its 10-year median of 3.35 and 328.2% above the Healthcare Providers & Services industry median of 11.00. FamiCord AG's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For FamiCord AG (VTIAF), the current 3-Year EPS without NRI Growth Rate is 47.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is FamiCord AG (VTIAF) Overvalued in 2026?
Based on GuruFocus' analysis, FamiCord AG stock appears to be undervalued.
The current stock price of $6.38 is trading 37.4% below its estimated GF Value™ of $10.18.
Key valuation signals for VTIAF:
3-Year EPS without NRI Growth Rate: 47.10% (1306% above median its 10-year median of 3.35)
GF Value™: $10.18 vs. price of $6.38 (37.4% below fair value)
Industry Position: 328.2% above the Healthcare Providers & Services median (#69 of 506)
No single metric tells the full story. See the VTIAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
FamiCord AG is an umbilical cord blood bank. It supplies cryopreservation and provides logistics for the collection of blood, preparation, and storage of stem cells from umbilical cord blood and tissue. The company is active in the areas of cell and gene therapies and CDMO. It continues to develop from a pure stem cell bank into a more broadly based cell bank that can supply available patients own cells for current and future cell therapies. Its services include stem cells banking, stem cells scientific proof, FamiCord contribution, stem cell applications list, stem cell applications stories, and stem cells banking for society. Its segments include Subgroup Vita 34 and Subgroup PBKM, which generate maximum revenue. It operates in Germany, Poland, Switzerland, and other foreign countries.
54GF Score
Get the complete analysis for VTIAF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTIAF has been successfully added to your 
